Waldenström's macroglobulinemia: Imbruvica prescribing information updated to include long-term data
The U.S. Food and Drug Administration ( FDA ) has approved the update of the Imbruvica ( Ibrutinib ) Prescribing Information to include efficacy and safety data for the combination of Imbruvica with ...
read article